Vertex Signs US$1.6 B Gene Therapy Vector Partnership with Affinia

By Michelle Liu

Pharma Deals Review: Vol 2020 Issue 5 (Table of Contents)

Published: 8 May-2020

DOI: 10.3833/pdr.v2020.i5.2535     ISSN: 1756-7874

Section: Research & Development



Continuing to invest in its gene therapy capabilities, Vertex Pharmaceuticals has agreed to partner with Affinia Therapeutics in a deal worth up to US$1...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details